New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer-Reference-Cited by-同舟云学术

New insights into the performance of multigene panel testing: Two novel nonsense variants in BRIP1 and TP53 in a young woman with breast cancer

Published:2018-12 Issue: Volume:228-229 Page:1-4
ISSN:2210-7762
Container-title:Cancer Genetics
language:en
Short-container-title:Cancer Genetics

Author:

Castillo-Guardiola Verónica,Sarabia-Meseguer M Desamparados^ORCID,Marín-Vera Miguel,Sánchez-Bermúdez Ana Isabel,Alonso-Romero José Luis^ORCID,Noguera-Velasco José Antonio,Ruiz-Espejo Francisco

Publisher

Elsevier BV

Subject

Cancer Research,Genetics,Molecular Biology

Reference12 articles.

1. The spectrum of genetic mutations in breast cancer;Sheikh;Asian Pac J Cancer Prev,2015

2. A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes;Buys;Cancer,2017

3. Managing patients at genetic risk of breast cancer;Pederson;Cleve Clin J Med,2016

4. Whole exome sequencing suggests much of non-BRCA1/BRCA2 familial breast cancer is due to moderate and low penetrance susceptibility alleles;Gracia-Aznarez;PLoS ONE,2013

5. SEOM clinical guidelines in hereditary breast and ovarian cancer;Llort;Clin Transl Oncol,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Immune Infiltration and Prognostic Biomarkers in Small Cell Lung Cancer Based on Bioinformatic Methods from 3 Studies;Combinatorial Chemistry & High Throughput Screening;2023-03

2. Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes;Genes;2023-02-08

3. Next step in molecular genetics of hereditary breast/ovarian cancer: Multigene panel testing in clinical actionably genes and prioritization algorithms in the study of variants of uncertain significance;European Journal of Medical Genetics;2022-04

4. Prominent Prognostic Factors in Aggressive Breast Cancer: A Review;International Journal of Cancer Management;2021-09-16

5. Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA;Thoracic Cancer;2020-05-15